Playing in the Real World Evidence Sandbox: Sharing, Teamwork, and Transparency
April Rieger2023-12-14T13:11:17-05:00November 19th, 2014|Categories: Blog, HEOR Feature|Tags: Allan Korn, Blue Cross and Blue Shield, clinical research, FDAMA 114, HE-Xpo, health care, Healtheconomics.com, HEOR, HExpo_RWE, late phase research, market access, Nathan White, Patients, Patti Peeples, payers, pharmaceutical, pricing, real world evidence, RWE, tHEORetically Speaking, virtual conferences|
Is just playing in the same sandbox together an example of Real World Evidence (RWE) collaboration? Not really. So how [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
HEOR
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Press Release
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication